WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc., an innovative molecular information company, announced today the appointment of Reymundo Lozano, MD to the company’s Clinical and Strategic Advisory Board.
“Dr. Lozano has deep domain knowledge in pediatric genetics, specifically in the areas of intellectual disabilities and the autism spectrum disorders,” states Brian McKernan, Chief Executive Officer of Courtagen. “We look forward to benefiting from Dr. Lozano’s insights as we continue to build a world class molecular information company.”
Help employers find you! Check out all the jobs and post your resume.